Clinical Trial Update: Thyroid Cancer and Sunitinib [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating sunitinib in patients with thyroid cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Cancer, Thyroid Carcinoma | Phase 2 | Status: COMPLETED